HAEのチャート
HAEの企業情報
| symbol | HAE |
|---|---|
| 会社名 | Haemonetics Corp. （HAE ヘモネティクス） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ヘモネティクス(Haemonetics Corporation)はヘルスケア会社である。同社は顧客向けに血液加工・取扱・分析に従事する。同社のセグメントには日本、EMEA、北米プラズマと他を含む。同社は、血漿分画装置が医薬品を製造することを可能にする血漿収集システムおよびソフトウェアを提供する。同社は血漿採取顧客が「PCS」というブランドの血漿採取器具および使い捨て器具、血漿採取容器および生理食塩水を含む血漿採取・保存に必要な製品の供給源を得ることを可能にする。同社は自動化血液成分および手動全血採取システムを採血センターに提供し、血液製剤を収集する。同社は血液管理ソリューションを提供する。同社には血液駆動計画と血液採取のためのソリューションを含む統合ソフトウェアソリューションがある。 ヘモネティクスは、米国のヘルスケア企業。血漿から血液採取装置、医療機関まで血液サプライチェ―ンの各段階に合わせた血液管理ソリュ―ションの他、集積デバイス、情報管理、およびコンサルティングサ―ビスを提供する。同社の製品は、血漿、血液センタ―、病院、ソフトウェアソリュ―ションに分かれる。 |
| 本社所在地 | 781 848-7100 |
| 代表者氏名 | Christopher Simon |
| 代表者役職名 | President Chief Executive Officer Director |
| 電話番号 | +1 781-848-7100 |
| 設立年月日 | 1971年 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 3136人 |
| url | www.haemonetics.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 209.40200 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 4462.11800 |
| 売上高 | 売上高（百万ドル） 951.83600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 4651.06400 |
| 当期純利益 | 当期純利益（百万ドル） 45.76400 |
| 決算概要 | 決算概要 BRIEF: For the 39 weeks ended 29 December 2018 Haemonetics Corporation revenues increased 7% to $718.3M. Net income before extraordinary items decreased 45% to $34.2M. Revenues reflect North America Plasma segment increase of 19% to $295.4M All other segment increase of 4% to $250.6M Japan segment increase of 3% to $52.2M United States segment increase of 10% to $452.5M Asia segment increase of 4% to $89.1M Japan segment increase of 6% to $52.3M. |
HAEのテクニカル分析
HAEのニュース
Autotransfusion Device Market With Leading Players like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated BD, Zimmer Biomet, BraileBiomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, Redax S.p.A. 2021/03/15 08:28:43 OpenPR
An off-the-shelf report on Autotransfusion Device Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as
Autotransfusion Devices and Consumables Market Is Expected To Exhibit 6.1% CAGR By 2026 | Getinge AB, Haemonetics Corporation 2021/03/12 09:55:25 OpenPR
Rapid technological advancements in the autotransfusion system, rise in prevalence of cardiovascular disease, and increasing adoption of autotransfusion systems are estimated the propel the growth of the global autotransfusion devices and consumables market The global autotransfusion devices and consumables market accounted
Haemonetics Prices $435.0 Million Convertible Senior Notes Offering 2021/03/03 01:22:00 PR Newswire
BOSTON, March 2, 2021 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.00% Convertible Senior Notes due 2026 (the "notes") in a private offering (the "offering") to qualified…
Haemonetics Announces Proposed Convertible Senior Notes Offering 2021/03/01 21:05:00 PR Newswire
BOSTON, March 1, 2021 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced its intention to offer, subject to market and other conditions, $425,000,000 aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private offering (the…
Haemonetics To Present At The Jefferies Plasma Summit 2021/02/26 11:50:00 PR Newswire
BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Jefferies Plasma Summit on Thursday, March 11, 2021, at 10:45 a.m. ET. The public may access Mr. Simon's video presentation live via webcast at:…
Autotransfusion Device Market With Leading Players like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated BD, Zimmer Biomet, BraileBiomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, Redax S.p.A. 2021/03/15 08:28:43 OpenPR
An off-the-shelf report on Autotransfusion Device Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as
Autotransfusion Devices and Consumables Market Is Expected To Exhibit 6.1% CAGR By 2026 | Getinge AB, Haemonetics Corporation 2021/03/12 09:55:25 OpenPR
Rapid technological advancements in the autotransfusion system, rise in prevalence of cardiovascular disease, and increasing adoption of autotransfusion systems are estimated the propel the growth of the global autotransfusion devices and consumables market The global autotransfusion devices and consumables market accounted
Haemonetics Prices $435.0 Million Convertible Senior Notes Offering 2021/03/03 01:22:00 PR Newswire
BOSTON, March 2, 2021 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.00% Convertible Senior Notes due 2026 (the "notes") in a private offering (the "offering") to qualified…
Haemonetics Announces Proposed Convertible Senior Notes Offering 2021/03/01 21:05:00 PR Newswire
BOSTON, March 1, 2021 /PRNewswire/ -- Haemonetics Corporation ("Haemonetics") (NYSE: HAE) today announced its intention to offer, subject to market and other conditions, $425,000,000 aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private offering (the…
Haemonetics To Present At The Jefferies Plasma Summit 2021/02/26 11:50:00 PR Newswire
BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Jefferies Plasma Summit on Thursday, March 11, 2021, at 10:45 a.m. ET. The public may access Mr. Simon's video presentation live via webcast at:…
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs 2021/02/10 12:34:42 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) argenx SE – ADR (NASDAQ: ARGX ) Arcus Biosciences Inc (NYSE: RCUS ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Assertio Holdings Inc (NASDAQ: ASRT ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) ChemoCentryx Inc (NASDAQ: CCXI ) Chimerix Inc (NASDAQ: CMRX ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) DarioHealth Corp (NASDAQ: DRIO ) Edap Tms SA (NASDAQ: EDAP ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Haemonetics Corporation (NYSE: HAE ) Fulgent Genetics Inc (NASDAQ: FLGT ) Halozyme Therapeutics, Inc.
Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website 2021/02/02 11:00:00 PR Newswire
BOSTON, Feb. 2, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2021, which ended December 26, 2020, are available on its Investor Relations website. The Company will host a conference call and webcast with investors…
Haemonetics snaps up Cardiva Medical for $510M 2021/01/20 18:00:00 BioWorld
Haemonetics Corp. said Wednesday that it will acquire Cardiva Medical Inc., a privately held manufacturer of blood closure systems, for up to $510 million. The all-cash deal expands Haemonetics’ hospital portfolio with two catheter-based devices used to shut off access sites following minimally invasive cardiology and electrophysiology (EP) procedures.
Needham Stick to Their Buy Rating for Haemonetics Corp. By Investing.com 2021/01/20 15:55:00 Investing.com
Needham Stick to Their Buy Rating for Haemonetics Corp.
Blood Management Devices Market Trends, Business Opportunities and to See Huge Growth by 2026 | Danaher Corporation, Becton, Dickinson and Company, Terumo BCT, Roche and Haemonetics Corporation 2021/01/16 19:31:19 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Blood Management Devices Key Trends and Opportunities to 2026”. The Global Blood Management Devices Market Report is a professional and in-depth study on the current state of